We are live on
!
Find out more
ESPR
Esperion Therapeutics
ESPR
ESPR
Delisted
ESPR was delisted on the 10th of July, 2026.
99 hedge funds and large institutions have $186M invested in Esperion Therapeutics in 2016 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 29 increasing their positions, 31 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
352% more call options, than puts
Call options by funds: $2.99M | Put options by funds: $661K
65.72% more ownership
Funds ownership: 0% → 65.72% (+66%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2% less capital invested
Capital invested by funds: $190M → $186M (-$4.45M)
6% less repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 31
2% less funds holding
Funds holding: 101 → 99 (-2)
12% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 17
Holders
99
Holders Change
-2
Holders Change %
-1.98%
% of All Funds
2.48%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
15
Increased
29
Reduced
31
Closed
17
Calls
$2.99M
Puts
$661K
Net Calls
+$2.33M
Net Calls Change
+$2.36M
Top Buyers
| 1 |
SAM
Senzar Asset Management
New York
|
+$4.33M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$3.64M |
| 3 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$3.48M |
| 4 |
BI
BVF Inc
San Francisco,
California
|
+$2.61M |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$2.01M |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$4.42M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$2.44M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.77M |
| 4 |
IHM
Iguana Healthcare Management
New York
|
-$1.11M |
| 5 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$1.04M |
